To test this hypothesis, we treated CD244fl/flLysMcre mice challenged with B16 melanoma with anti-PD-L1 antibody and compared the tumor growth with control CD244fl/fl mice (Fig. 6A). The gene discussed is CD274; the disease is neoplasm.